-
Adamis Pharma Soars 60% Amid New Partnership With Novartis To Commercialize Symjepi
Monday, July 2, 2018 - 10:14am | 373Shares of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) soared higher by 60 percent early Monday morning in reaction to a new partnership with Novartis AG (ADR) (NYSE: NVS). What Happened Adamis, a specialty biopharmaceutical company that focuses on treatments for respiratory diseases and...
-
What Makes Mylan's Newest EpiPen Lawsuit Different?
Monday, April 10, 2017 - 2:01pm | 900Mylan N.V. (NASDAQ: MYL), which has faced a plethora of lawsuits in the past over its EpiPen, is now being saddled with another lawsuit, although this time around the parties involved go beyond the company and the plaintiffs. EpiPen And Its Legal Tussle EpiPen, or an epinephrine auto injector is...
-
Food Allergy Bill Offers Financial Incentives for States That Have Emergency Meds at Schools
Wednesday, November 13, 2013 - 3:22pm | 637If you have a school-age child, you probably know how serious the issue of food allergies -- and an allergic reaction -- can be. The Centers for Disease Control and Prevention says about 88 percent of the nation's schools have one or more students with a serious food allergy – a health...